mRNA Therapeutics— Companies & Signals
mRNA therapeutics leverage the body's own cellular machinery to produce therapeutic proteins or antibodies, offering a versatile platform for treating a wide range of diseases. This technology's rapid development and adaptability, particularly with advancements in lipid nanoparticle delivery, position it as a significant growth area with potential to revolutionize medicine. 27 public companies above the $50M floor. Last 90 days: 18 red 8-Ks, 0 insider cluster-buys, 2 running hot in the press.
27
Companies
18
Red 8-Ks · 90d
0
Insider clusters
2
🔥 Media-hot
Companies in mRNA Therapeutics
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | $198.1M | -0.9% | -5.7% | 395K | — | red 8-K |
| 2 | WVE | Wave Life Sciences Ltd. | Healthcare | $1.1B | -2.6% | -7.9% | 2.7M | — | |
| 3 | CRSP | CRISPR Therapeutics AG | Healthcare | $4.9B | +2.6% | +3.7% | 1.8M | ⚡ | red 8-K |
| 4 | ABUS | Arbutus Biopharma Corp | Healthcare | $841.5M | +2.2% | +3.5% | 2.5M | — | red 8-K |
| 5 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | Healthcare | $37.8B | +0.7% | +2.5% | 1.4M | — | red 8-K |
| 6 | MRNA | Moderna, Inc. | Healthcare | $19.8B | +3.6% | +17.4% | 8.1M | 🔥 | |
| 7 | CAPR | CAPRICOR THERAPEUTICS, INC. | Healthcare | $1.5B | -10.0% | -18.9% | 3.2M | — | |
| 8 | VALN | Valneva SE | Healthcare | $507.8M | -0.4% | -3.4% | 37K | — | |
| 9 | TRDA | Entrada Therapeutics, Inc. | Healthcare | $250.8M | -0.4% | +9.1% | 240K | — | red 8-K |
| 10 | PRQR | ProQR Therapeutics N.V. | Healthcare | $151.7M | +19.6% | -2.7% | 2.6M | — | |
| 11 | ROIV | Roivant Sciences Ltd. | Healthcare | $21.6B | +1.9% | +11.1% | 6.4M | — | |
| 12 | ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Healthcare | $10.5B | +2.0% | -1.8% | 1.7M | — | red 8-K |
| 13 | PRME | Prime Medicine, Inc. | Healthcare | $501.2M | +8.4% | +10.4% | 5.3M | — | red 8-K |
| 14 | CAMP | Camp4 Therapeutics Corp | Healthcare | $217.6M | +5.7% | +5.7% | 157K | — | red 8-K |
| 15 | HURA | TuHURA Biosciences, Inc./NV | Healthcare | $147.7M | +6.0% | -15.5% | 794K | — | red 8-K |
| 16 | EDIT | Editas Medicine, Inc. | Healthcare | $383.7M | +12.3% | +14.3% | 3.0M | — | red 8-K |
| 17 | A | AGILENT TECHNOLOGIES, INC. | Healthcare | $36.7B | -2.3% | +5.0% | 2.0M | 🔥 | red 8-K |
| 18 | WHWK | Whitehawk Therapeutics, Inc. | Healthcare | $205.7M | +6.0% | -1.1% | 364K | — | |
| 19 | MXCT | MAXCYTE, INC. | Healthcare | $120.0M | 0.0% | +5.1% | 1.2M | — | red 8-K |
| 20 | AVIR | Atea Pharmaceuticals, Inc. | Healthcare | $359.3M | +2.7% | +5.0% | 516K | — | |
| 21 | WAT | WATERS CORP /DE/ | Healthcare | $34.9B | -1.5% | +3.0% | 981K | ⚡ | |
| 22 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Healthcare | $11.1B | +2.9% | +2.8% | 447K | — | red 8-K |
| 23 | CTMX | CytomX Therapeutics, Inc. | Healthcare | $655.3M | +10.0% | +23.0% | 7.0M | — | red 8-K |
| 24 | BNTC | Benitec Biopharma Inc. | Healthcare | $384.1M | +2.7% | +3.3% | 98K | — | red 8-K |
| 25 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | $12.1B | -0.6% | +6.3% | 2.8M | — | red 8-K |
| 26 | PGEN | PRECIGEN, INC. | Healthcare | $1.6B | +1.0% | +10.0% | 6.3M | — | red 8-K |
| 27 | DTIL | PRECISION BIOSCIENCES INC | Healthcare | $157.4M | +8.6% | +11.9% | 775K | — | red 8-K |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.